JPWO2020254484A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020254484A5
JPWO2020254484A5 JP2021575316A JP2021575316A JPWO2020254484A5 JP WO2020254484 A5 JPWO2020254484 A5 JP WO2020254484A5 JP 2021575316 A JP2021575316 A JP 2021575316A JP 2021575316 A JP2021575316 A JP 2021575316A JP WO2020254484 A5 JPWO2020254484 A5 JP WO2020254484A5
Authority
JP
Japan
Prior art keywords
isolated compound
compound
isolated
mitochondrial
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021575316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538009A (ja
JP2022538009A5 (https=
JP7699551B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066923 external-priority patent/WO2020254484A1/en
Publication of JP2022538009A publication Critical patent/JP2022538009A/ja
Publication of JPWO2020254484A5 publication Critical patent/JPWO2020254484A5/ja
Publication of JP2022538009A5 publication Critical patent/JP2022538009A5/ja
Priority to JP2024176276A priority Critical patent/JP7827801B2/ja
Application granted granted Critical
Publication of JP7699551B2 publication Critical patent/JP7699551B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021575316A 2019-06-19 2020-06-18 コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用 Active JP7699551B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024176276A JP7827801B2 (ja) 2019-06-19 2024-10-08 コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA201970382 2019-06-19
DKPA201970383 2019-06-19
DKPA201970382 2019-06-19
DKPA201970384 2019-06-19
DKPA201970383 2019-06-19
DKPA201970384 2019-06-19
PCT/EP2020/066923 WO2020254484A1 (en) 2019-06-19 2020-06-18 Succinate prodrug, compositions containing the succinate prodrug and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024176276A Division JP7827801B2 (ja) 2019-06-19 2024-10-08 コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用

Publications (4)

Publication Number Publication Date
JP2022538009A JP2022538009A (ja) 2022-08-31
JPWO2020254484A5 true JPWO2020254484A5 (https=) 2023-06-28
JP2022538009A5 JP2022538009A5 (https=) 2023-06-28
JP7699551B2 JP7699551B2 (ja) 2025-06-27

Family

ID=71130953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021575316A Active JP7699551B2 (ja) 2019-06-19 2020-06-18 コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用
JP2024176276A Active JP7827801B2 (ja) 2019-06-19 2024-10-08 コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024176276A Active JP7827801B2 (ja) 2019-06-19 2024-10-08 コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用

Country Status (11)

Country Link
US (2) US11565998B2 (https=)
EP (2) EP4360708A3 (https=)
JP (2) JP7699551B2 (https=)
KR (1) KR102871719B1 (https=)
CN (1) CN113993842B (https=)
AU (1) AU2020298031B2 (https=)
CA (1) CA3143112A1 (https=)
IL (1) IL288990B2 (https=)
MA (1) MA56506A (https=)
MX (1) MX2021015137A (https=)
WO (1) WO2020254484A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612331D0 (en) 1996-06-13 1996-08-14 Leo Pharm Prod Ltd Chemical compounds
AUPR059400A0 (en) 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
PL3129016T3 (pl) 2014-04-08 2018-10-31 Neurovive Pharmaceutical Ab Nowe przepuszczalne dla komórek związki bursztynianu
SG11201607908QA (en) * 2014-04-08 2016-10-28 Neurovive Pharmaceutical Ab Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex i-related impairment of mitochondrial oxidative phosphorylation
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Similar Documents

Publication Publication Date Title
JP4138886B2 (ja) ２−アミノ−４−（４−フルオルベンジルアミノ）−１−エトキシカルボニル−アミノベンゼンの新規変態ならびにその製造法
JP4104687B2 (ja) Ｃｄｃｈの新規な結晶変態、その製造法及びこの変態を含む製薬学的調剤
CN1243541C (zh) 2－(α－羟基戊基)苯甲酸盐及其制法和用途
RU2419621C2 (ru) Гетероциклические соединения, пригодные для использования в качестве анаболических агентов скота
JPS62161763A (ja) ７‐アミノ‐１シクロプロピル‐４‐オキソ‐１，４‐ジヒドロ‐ナフチリジンまたは‐キノリン‐３‐カルボン酸類またはその塩及びそれらの製造法
EP2007758B1 (en) A novel crystalline form of lamivudine
JP2003513062A (ja) 塩酸セルトラリンの多形形態
WO2014071772A1 (zh) 吡咯并喹啉醌的二钠盐结晶
CN110818634B (zh) 甲磺酸乐伐替尼的精制方法
MC1231A1 (fr) Nouveaux benzamides heterocycliques substitues,leurs procedes de preparation et leur application comme modificateurs du comportement
EP1890994B1 (de) Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin
TWI815820B (zh) ２－（５－（４－（２－嗎啉乙氧基）苯基）吡啶－２－基）－ｎ－芐乙醯胺之固態形式
CZ2003140A3 (cs) Nová forma (R)-N-[5-methyl-8-(4-methylpiperazin-l-yl)-1,2,3,4-tetrahydro-2-naftyl]-4-morfolinobenzamidu
EP0335164A2 (de) Neopentylesterderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN102675395A (zh) 醋酸乌利司他的多晶型及其制备方法
EP2362870A2 (en) Novel processes and pure polymorphs
WO2000078729A1 (en) Crystalline forms of lansoprazole
JPWO2020254484A5 (https=)
CN112028896A (zh) 阿卡替尼的新晶型及其制备方法
JP6400580B2 (ja) ３−ホルミルリファマイシンｓｖ及び３−ホルミルリファマイシンｓの３−（４−シンナミル−１−ピペラジニル）アミノ誘導体を含有する医薬製剤並びにこれらの製造方法
JPH0365338B2 (https=)
CN1880294B (zh) 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物
US2727041A (en) Isonicotinyl hydrazone of m-formyl-benzene sulfonic acid
CN106866533A (zh) 吡唑醚菌酯晶型及制备方法
AU2007232198B2 (en) Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use